000			02147 a2200589 4500
005			20250514184310.0
264		0	_c20040720
008			200407s 0 0 eng d
022			_a0954-7894
024	7		_a10.1111/j.1365-2222.2004.1916.x _2doi
040			_aNLM _beng _cNLM
100	1		_aHolgate, S T
245	0	0	_aEfficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. _h[electronic resource]
260			_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _cApr 2004
300			_a632-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAndrostadienes _xadministration & dosage
650	0	4	_aAnti-Asthmatic Agents _xadverse effects
650	0	4	_aAntibodies, Anti-Idiotypic _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aChild
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFluticasone
650	0	4	_aHumans
650	0	4	_aImmunoglobulin E _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOmalizumab
650	0	4	_aQuality of Life
650	0	4	_aTreatment Outcome
700	1		_aChuchalin, A G
700	1		_aHébert, J
700	1		_aLötvall, J
700	1		_aPersson, G B
700	1		_aChung, K F
700	1		_aBousquet, J
700	1		_aKerstjens, H A
700	1		_aFox, H
700	1		_aThirlwell, J
700	1		_aCioppa, G Della
773	0		_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 34 _gno. 4 _gp. 632-8
856	4	0	_uhttps://doi.org/10.1111/j.1365-2222.2004.1916.x _zAvailable from publisher's website
999			_c14794429 _d14794429